Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery

Surgery (United States)

Volumn 163, Issue 4, 2018, Pages 753-760

  Swords, Douglas S ^a   Zhang, Chong ^a   Presson, Angela P ^a   Firpo, Matthew A ^a   Mulvihill, Sean J ^a   Scaife, Courtney L ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL OUTCOME; FEMALE; FRAILTY; HEALTH INSURANCE; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; LOW VOLUME HOSPITAL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOADJUVANT THERAPY; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; TIME TO TREATMENT; UNITED STATES; ADENOCARCINOMA; MIDDLE AGED; PANCREAS TUMOR; PANCREATECTOMY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 85039035123     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2017.10.054     Document Type: Article

References (26)

1. Institute of Medicine, Crossing the quality chasm: a new health system for the 21st century. http://www.nationalacademies.org/hmd/~/media/Files/Report%20Files/2001/Crossing-the-Quality-Chasm/Quality%20Chasm%202001%20%20report%20brief.pdf, 2001.
2. Bilimoria, K.Y.K.C., Tomlinson, J.S., Stewart, A.K., et al. Wait times for cancer surgery in the united states: trends and predictors of delays. Ann Surg 253 (2011), 779–785.
3. Murphy, C.T., Galloway, T.J., Handorf, E.A., et al. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database. Cancer 121 (2015), 1204–1213.
4. Yu, J., Blackford, A.L., Dal Molin, M., Wolfgang, C.L., Goggins, M., Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages. Gut 64 (2015), 1783–1789.
5. NCCN clinical practice guidelines in oncology: pancreatic adenocarcinoma. Version 3. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp, 2017. (Accessed 24 September 2017)
6. Tzeng, C.W., Katz, M.H., Fleming, J.B., et al. Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification. J Gastrointest Surg 18 (2014), 146–155 discussion 55-6.
7. Sanjeevi, S., Ivanics, T., Lundell, L., et al. Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Br J Surg 103 (2016), 267–275.
8. Raptis, D.A., Fessas, C., Belasyse-Smith, P., Kurzawinski, T.R., Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Surgeon 8 (2010), 239–246.
9. McLean, S.R., Karsanji, D., Wilson, J., et al. The effect of wait times on oncological outcomes from periampullary adenocarcinomas. J Surg Oncol 107 (2013), 853–858.
10. Jooste, V., Dejardin, O., Bouvier, V., et al. Pancreatic cancer: wait times from presentation to treatment and survival in a population-based study. Int J Cancer 139 (2016), 1073–1080.
11. Eshuis, W.J., van der Gaag, N.A., Rauws, E.A., et al. Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Ann Surg 252 (2010), 840–849.
12. Amr, B., Shahtahmassebi, G., Briggs, C.D., Bowles, M.J., Aroori, S., Stell, D.A., Assessment of the effect of interval from presentation to surgery on outcome in patients with peri-ampullary malignancy. HPB (Oxford) 18 (2016), 354–359.
13. Glant, J.A., Waters, J.A., House, M.G., et al. Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma?. Surgery 150 (2011), 607–616.
14. Raman, S.P., Reddy, S., Weiss, M.J., et al. Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer. AJR Am J Roentgenol 204 (2015), W37–W42.
15. Boffa, D.J., Rosen, J.E., Mallin, K., et al. Using the National Cancer Database for outcomes research: a review. JAMA Oncol, 2017, 10.1001/jamaoncol.2016.6905.
16. Bilimoria, K.Y., Bentrem, D.J., Ko, C.Y., Stewart, A.K., Winchester, D.P., Talamonti, M.S., National failure to operate on early stage pancreatic cancer. Ann Surg 246 (2007), 173–180.
17. Swords, D.S., Mulvihill, S.J., Skarda, D.E., et al. Hospital-level variation in utilization of surgery for clinical stage I-II pancreatic adenocarcinoma. Ann Surg, 2017, 10.1097/SLA.0000000000002404.
18. Gaujoux, S., Brennan, M.F., Gonen, M., et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg 212 (2011), 590–600 discussion -3.
19. Desquilbet, L., Mariotti, F., Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29 (2010), 1037–1057.
20. Cuzick, J., A Wilcoxon-type test for trend. Stat Med 41 (1985), 87–90.
21. Schisterman, E.F., Cole, S.R., Platt, R.W., Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 20 (2009), 488–495.
22. Sauer, B.C., Brookhart, M.A., Roy, J., VanderWeele, T., A review of covariate selection for non-experimental comparative effectiveness research. Pharmacoepidemiol Drug Saf 22 (2013), 1139–1145.
23. van der Gaag, N.A., Rauws, E.A., van Eijck, C.H., et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362 (2010), 129–137.
24. Lyons, J.M., Karkar, A., Correa-Gallego, C.C., et al. Operative procedures for unresectable pancreatic cancer: does operative bypass decrease requirements for postoperative procedures and in-hospital days?. HPB (Oxford) 14 (2012), 469–475.
25. Spanheimer, P.M.C.A., Liao, J., Johlin, F.C., Hoshi, H., Howe, J.R., Mezhir, J.J., Complications and survival associated with operative procedures in patients with unresectable pancreatic head adenocarcinoma. J Surg Oncol 109 (2014), 697–701.
26. Mokdad, A.A., Minter, R.M., Zhu, H., Mansour, J.C., Choti, M.A., Polanco, P.M., Reply to J. Bergquist et al and T.-Y. Lai et al. J Clin Oncol 35 (2017), 1624–1625.